Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder

View at publisher
Authors: Per Damkier, Erika Angelica Björkström Gram, M Ceulemans, A Panchaud, B Cleary, C Chambers, Corinna Weber‐Schoendorfer, D Kennedy, K Hodson, KS Grand, Orna Diav‐Citrin, SG Običan
+2 more Svetlana Shechtman, S Alwan
Cited by: 0

Abstract

( Obstet Gynecol . 2025;145:168-176. doi: 10.1097/AOG.0000000000005802.) Acetaminophen use during pregnancy is considered standard for pain relief and fever. Other treatments are available, but many do not have enough evidence for safety and effectiveness during pregnancy or have evidence showing increased risks of miscarriage or other adverse outcomes. An estimated 40% to 65% of women take acetaminophen during pregnancy, though estimates vary. Results of studies on acetaminophen use during pregnancy have been inconsistent, with some showing links to long-term reproductive tract or neurobehavioral outcomes and some showing no significant link. One area of major public interest is the association of acetaminophen use during pregnancy with attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Though some studies have suggested links to these conditions, clinical recommendations have not changed, and there is much controversy surrounding the issue. This study is a clinical review of the pivotal epidemiologic studies that have evaluated the effects of maternal acetaminophen use during pregnancy and its association with ADHD and ASD.

Fields of Study & Subjects

Pregnancy and Medication Impact Prenatal Substance Exposure Effects Attention Deficit Hyperactivity Disorder

Publication details

Journal / source
Obstetric Anesthesia Digest
Volume
46
Issue
1
Pages
23–24
Publication date
1 March 2026
Language
EN